Dendreon Corporation (DNDN) 35.17 -1.13

Trade DNDN
NOW!
Last Trade:35.03Short Ratio:3.70
Last Trade Time:4:00pmDay Range:34.94 - 36.29
Ask:35.17Year Range:3.94 - 37.09
Bid:34.95One Year Target:39.27
Open:36.22Exchange:NGM
Volume:4545484EBITDA:-95.4M
Prev. Close:36.16Market Cap:4.699B
50 Day Moving:32.4922Div Yield:
200 day moving:28.6734PE:

DNDN's Provenge To Be First Approved Cancer Immunotherapy

Analysts at RW Baird initiate coverage of Dendreon (NASDAQ: DNDN) with an "outperform" rating. The target price for DNDN is set to $48. According to RW Baird, Provenge is expected to be the first approved immunotherapy for cancer. RW Baird recommends buying Dendreon's shares into the high $40’s.

DNDN Initiated With Outperform At RW Baird

Analysts at RW Baird initiate coverage of Dendreon (NASDAQ: DNDN) with an "outperform" rating. The target price for DNDN is set to $48. DNDN’s shares closed at $36.01 yesterday. More Analyst Ratings here

Analyst Upgrades for March 12th

Analyst Upgrades for 3/12/2010... Aeropostale (NYSE: ARO) upgraded to Neutral from Underweight, $31 target, at Piper Jaffray... Amylin Pharma (NASDAQ: AMLN) initiated as Buy at Jefferies...

Cleantech Goes Mainstream at ROTH Capital Partners 22nd Annual OC Growth Stock Conference March 15-17, 2010

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- ROTH Capital Partners (ROTH), www.roth.com, a full service investment bank recognized for providing finan

Notable Biotech Stocks Movers (OSIP, DNDN, MDVN, GILD, AMGN)

(EMAILWIRE.COM, March 10, 2010 ) Dallas , Tx - OSI Pharmaceuticals, Inc. (NASDAQ:OSIP) added 1.24% to close at $57 on 1.73 million shares. The stock is very close to its 52-week high of $57.30. You can subscribe to these free stock alerts at http://www.PennyStockPickAlert.com

Biotech Stocks Top Gainers are (GNVC, XNPT, DNDN, INCY, HGSI, CERS)

(EMAILWIRE.COM, March 09, 2010 ) Dallas, Tx - GenVec, Inc. (NASDAQ:GNVC) surged 4.73% to $3.32 in the early morning trade. Today it announced that Douglas J.

Notable Biotech Movers (OSIP, NBIX, HGSI, DNDN, AMLN, MDVN, CTIC)

(EMAILWIRE.COM, March 09, 2010 ) Dallas, Tx - OSI Pharmaceuticals, Inc. (NASDAQ:OSIP) lost 1.21% to close at $56.30 on 1.93 million shares. The stock is very close to its 52-week high of $57.30. You can subscribe to these free stock alerts at http://www.PennyStockPickAlert.com

Media & Internet Companies Get Spotlight at ROTH Capital Partners 22nd Annual OC Growth Stock Conference March 15-17, 2010

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- ROTH Capital Partners (ROTH), www.roth.com, a full service investment bank recognized for providing finan

Company News for March 8, 2010 - Corporate Summary

• AIG (NYSE:AIG) is reportedly close to a deal to sell its international unit, Alico, to MetLife (NYSE:MET) for $15.5 billion in cash and stock • Toyota Motor (NYSE:TM) president expects the auto-maker's North American sales could recover in March • The Bank of NY Mellon (NYSE:BK) agreed to purchase Germany's BHF Asset Servicing GmbH for about $343 million

Comtex SmarTrend(R) Morning Call -- March 8, 2010

Stocks had been waiting to jump, and did so when better labor news catalyzed the expected rally on Friday. The DJIA climbed 122 points for the day to close at 10,566. The SmarTrend(R) indicators gained more ground, and continue to point the way for the DJIA to rise to 10,700 before pausing at overhead resistance.